NCT04798079Active, not recruiting
Systems Biology of Early Atopy
Source: ClinicalTrials.gov · Last updated 27 May 2026
Brief summary (registry, in English)
The goal of this study is to establish a birth cohort that collects prenatal and early life biosamples and environmental samples and rigorously phenotypes young children for food allergy and Atopic Dermatitis (AD) to identify prenatal and early life markers of high risk for food allergy and AD, as well as biological pathways (endotypes) that result in these conditions. Primary Objectives: * To study the role and interrelationships of established and novel clinical, environmental, biological, and genetic prenatal and early-life factors in the development and course of allergic diseases through age 3 years (or 6 years for those who choose to continue participation into SUNBEAM II), with an emphasis on atopic dermatitis and food allergy * To apply systems biology to identify mechanisms and biomarkers underlying the development of food allergy, atopic dermatitis, and their endotypes * To collect, process, and assay or store environmental and biological samples for current and future use in the study of allergic disease development
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 2500 (estimated)
- First submitted
- 5 Mar 2021
- Start date
- 18 Mar 2021
- Primary completion date
- Jul 2032
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT04798079
What you commit to
- Study type: Observational
- Planned participants: 2500
- From 18 Mar 2021 to the primary completion date, Jul 2032
- 13 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Serious pregnancy complication (in the judgement of the investigator) prior to enrollment
Other illness
- Born with a significant birth defect or medical condition, and in the judgment of the investigators, participation is not in the infant's best interest
- Biological Father-
- 1\. Biological fathers who are unable or unwilling to comply with the study protocol as it pertains to the biological father's participation are not eligible for enrollment
- ----Note Regarding Legal Guardians who are not the Biological Parents:
Other
- Pregnant Women-
- Pregnant women who meet any of these criteria are not eligible for enrollment:
- Inability or unwillingness to comply with study protocol
- Fetus has a major chromosomal anomaly
- Plans to move and would not be available for in-person visits at a study site
- Plans to give up her child for adoption at birth
- Pregnancy is the result of an egg donation
- Infants-
- Infants who meet any of these criteria are not eligible for enrollment:
- Delivered earlier than 34 weeks of gestation
- Sibling already enrolled
- At screening for enrollment of either the mother or the child, if the biological mother intends to give the infant up for adoption, neither the mother nor the child are eligible for enrollment
- If the biological mother gives up legal guardianship of the child during the child's follow-up period, the child may remain enrolled as long as the new legal guardian:
- Agrees to meet the child's study requirements, and
- Provides written informed consent for the child's continued participation.
- Throughout the protocol where it refers to the mother, father, or parent answering questionnaires about the child or collecting samples from the child and the child's primary home, the legal guardian who provides consent for the child's participation may complete those procedures
Who the study is looking for
- Pregnant Women-
- Pregnant women who meet all of the following criteria are eligible for enrollment as study participants:
- Age 18 years or older
- Able to understand the oral and written instructions associated with study visits and procedures and provide informed consent
- Pregnant at any stage
- Planning to give birth at a study-site designated center
- Agrees to enroll offspring into the study at birth
- In the case of multiple gestation, agrees to enroll only one child who will be selected by randomized birth order
- Biological Fathers-
- Biological fathers who meet all of the following criteria are eligible for enrollment as study participants:
- Age 18 years or older
- Able to understand the oral and written instructions associated with study visits and procedures and provide informed consent
Age in the registry: 0 years to - · Sex: All · Accepts healthy volunteers
Sites (13)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Johns Hopkins Children's Center, Department of Allergy & Immunology Coordinator of this site? Confirm its status | Baltimore | United States | Unknown status |
| Massachusetts General Hospital, Translational and Clinical Research Center Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
| North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology Coordinator of this site? Confirm its status | Chapel Hill | United States | Unknown status |
| Northwestern University Feinberg School of Medicine: Dept of Dermatology Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
| Cincinnati Children's Hospital Medical Center Coordinator of this site? Confirm its status | Cincinnati | United States | Unknown status |
| National Jewish Health Coordinator of this site? Confirm its status | Denver | United States | Unknown status |
| Henry Ford Health System, Division of Allergy and Immunology Coordinator of this site? Confirm its status | Detroit | United States | Unknown status |
| Texas Children's Hospital Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
| Arkansas Children's Hospital Coordinator of this site? Confirm its status | Little Rock | United States | Unknown status |
| University of Wisconsin School of Medicine and Public Health Coordinator of this site? Confirm its status | Madison | United States | Unknown status |
| Vanderbilt University Medical Center Department of Pediatrics Division of Pediatric Allergy, Immunology, and Pulmonary Medicine Coordinator of this site? Confirm its status | Nashville | United States | Unknown status |
| Kravis Children's Hospital, Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai Coordinator of this site? Confirm its status | New York | United States | Unknown status |
| Sean N. Parker Center for Allergy & Asthma Research at Stanford University Coordinator of this site? Confirm its status | Stanford | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.